Département Médicaments et Technologies pour la Santé (DMTS), Université Paris-Saclay, CEA, INRAE, Bagnols-sur-Cèze, France.
Environ Microbiol. 2023 Jan;25(1):115-125. doi: 10.1111/1462-2920.16238. Epub 2022 Oct 18.
In the medical, environmental, and biotechnological fields, microbial communities have attracted much attention due to their roles and numerous possible applications. The study of these communities is challenging due to their diversity and complexity. Innovative methods are needed to identify the taxonomic components of individual microbiota, their changes over time, and to determine how microoorganisms interact and function. Metaproteomics is based on the identification and quantification of proteins, and can potentially provide this full picture. Due to the wide molecular panorama and functional insights it provides, metaproteomics is gaining momentum in microbiome and holobiont research. Its full potential should be unleashed in the coming years with progress in speed and cost of analyses. In this exploratory crystal ball exercise, I discuss the technical and conceptual advances in metaproteomics that I expect to drive innovative research over the next few years in microbiology. I also debate the concepts of 'microbial dark matter' and 'Metaproteomics-Assembled Proteomes (MAPs)' and present some long-term prospects for metaproteomics in clinical diagnostics and personalized medicine, environmental monitoring, agriculture, and biotechnology.
在医学、环境和生物技术领域,由于微生物群落的作用和众多可能的应用,它们引起了广泛关注。由于其多样性和复杂性,研究这些群落具有挑战性。需要创新的方法来识别个体微生物群落的分类组成、它们随时间的变化,以及确定微生物如何相互作用和发挥功能。代谢组学基于蛋白质的鉴定和定量,并且可以潜在地提供这种全面的图景。由于它提供了广泛的分子全景和功能见解,代谢组学在微生物组和整体生物研究中正在获得动力。随着分析速度和成本的提高,其全部潜力将在未来几年得到释放。在这项探索性的水晶球练习中,我讨论了代谢组学中我预计将在未来几年推动微生物学创新研究的技术和概念进展。我还讨论了“微生物暗物质”和“代谢组学组装蛋白质(MAPs)”的概念,并提出了代谢组学在临床诊断和个性化医学、环境监测、农业和生物技术方面的一些长期前景。